MTOR and endometrial carcinoma: To investigate the mechanisms underlying the effects of CD47 on endometrial carcinoma, western blot was performed to measure PI3K/Akt/mTOR signaling pathway protein levels after injection of CD47 plasmid into endometrial carcinoma cells.